Saint-Denis, France —An exhibition titled *”Croire et guérir”* (“Believe and Heal”) opens this week at the Musée d’Ethnographie, showcasing traditional herbal remedies, grigris (protective amulets), and indigenous healing practices from West and Central Africa. Curated by anthropologist Dr. Amina Diop of the Université Paris Cité, the exhibit explores how cultural beliefs shape healthcare access in underserved communities, where 40% of the population relies on traditional medicine as a primary treatment source, according to a 2025 WHO report on African healthcare systems. The display includes rare 19th-century herbariums from Senegal and Benin, alongside modern clinical studies on plant-based therapies—raising questions about integration, regulation, and the risks of untested remedies.
Why This Exhibition Matters: Bridging Traditional and Evidence-Based Medicine
The *”Croire et guérir”* exhibit arrives as France’s public health system grapples with a 12% annual increase in demand for complementary therapies, per data from the French National Agency for Medicines and Health Products Safety (ANSM). While traditional medicines account for 80% of healthcare use in rural African regions, their integration into formal systems remains contentious. The exhibition forces a reckoning: How can culturally rooted practices be evaluated for safety and efficacy without erasing their symbolic value?
Dr. Diop’s work aligns with a growing body of research on phytotherapy—the use of plant-derived compounds in medicine. A 2023 Lancet study found that 60% of modern pharmaceuticals originate from natural sources, yet only 2% of these undergo rigorous clinical trials before market entry. The exhibition’s herbariums, for example, include specimens of Artemisia annua (the source of artemisinin, a malaria treatment), yet historical records show these plants were used empirically for centuries before their mechanisms were understood.
In Plain English: The Clinical Takeaway
- Traditional ≠ Unsafe: Many plant-based remedies have active compounds (e.g., quinine from cinchona bark) that later became pharmaceuticals. However, dosage and preparation often lack standardization.
- Cultural Context Matters: In communities where distrust of hospitals persists, traditional healers may be the only accessible care providers—especially for chronic conditions like hypertension or diabetes.
- Regulation is Lagging: France’s ANSM regulates herbal products under a simplified registration pathway, but this excludes many traditional remedies used in Africa, creating a legal gray area.
How Traditional Remedies Stack Up: Efficacy, Risks, and Global Precedents
The exhibition highlights a paradox: while some traditional medicines have proven efficacy (e.g., Rauwolfia serpentina for hypertension), others carry unverified claims. A 2024 study in Nature Plants analyzed 500 African herbal remedies and found that only 12% had documented safety profiles in peer-reviewed trials. This gap mirrors challenges in other regions—such as Ayurvedic medicines in India, where 30% of formulations contain heavy metals like lead, per a 2022 JAMA Network Open investigation.
“The issue isn’t whether traditional medicine works—it’s whether we’re testing it the right way. Many of these remedies have been refined over generations, but without modern pharmacovigilance, we’re flying blind on interactions or long-term effects.”
France’s approach contrasts with other European nations. Germany’s Commission E (a scientific advisory body) has evaluated over 350 herbal monographs, while the UK’s MHRA requires traditional use data spanning 30 years for registration. The EU’s Herbal Medicinal Products Directive (2004/24/EC) sets minimum standards, but enforcement varies. In France, traditional remedies sold as “food supplements” (not medicines) escape scrutiny entirely.
| Region | Regulatory Framework | Percentage of Population Using Traditional Medicine | Key Challenge |
|---|---|---|---|
| France (Metropolitan) | ANSM’s simplified registration for herbal medicines; no oversight for “traditional use” claims | 12% (rising) | Lack of harmonization with African practices |
| Germany | Commission E monographs; strict pharmacopeia standards | 8% | High compliance costs for small manufacturers |
| West Africa (Senegal/Benin) | No centralized regulation; reliance on WHO’s Traditional Medicine Strategy (2013–2023) | 80%+ | Counterfeit remedies and mislabeling |
Funding the Gap: Who’s Behind the Research—and Why It Matters
The exhibition’s clinical data comes from two key sources: a 2025 Wellcome Trust-funded study on African medicinal plants (£2.1 million grant) and a French National Research Agency (ANR) project on ethnopharmacology. However, funding disparities persist. While the EU allocated €150 million to traditional medicine research in 2023, African nations contributed just 3% of that total, per the WHO’s Global Report on Traditional and Complementary Medicine.
Critics argue that pharmaceutical companies exploit traditional knowledge without compensation. A 2024 Science investigation found that 75% of patents for plant-derived drugs list Western institutions as inventors, despite African communities providing the raw materials. The Nagoya Protocol (2010), which mandates benefit-sharing, remains under-enforced in France.
Contraindications & When to Consult a Doctor
While some traditional remedies are safe, others pose risks—especially when mixed with conventional drugs. The following scenarios warrant medical attention:
- Severe allergic reactions: Herbs like Echinacea or Ginkgo biloba can trigger anaphylaxis in sensitive individuals. The CDC reports 5,000 annual hospitalizations in the U.S. alone from herbal supplement-related adverse events.
- Drug interactions: St. John’s Wort (used for depression) induces liver enzymes, reducing the efficacy of birth control pills by up to 30%, per a 2023 British Journal of Clinical Pharmacology meta-analysis.
- Chronic conditions: Diabetes or hypertension patients using bitter melon (Momordica charantia) or hawthorn should monitor blood sugar/pressure closely—these herbs can potentiate insulin or antihypertensives.
- Pregnancy/lactation: Many traditional remedies (e.g., black cohosh, blue cohosh) are contraindicated due to uterine-stimulating effects. The FDA warns against their use without provider oversight.
What Happens Next: Policy, Research, and Patient Access
The exhibition’s legacy may hinge on two parallel tracks: clinical validation and cultural preservation. France’s ANSM is reviewing proposals to create a “traditional medicine registry,” but progress is slow. Meanwhile, the WHO’s Traditional Medicine Collaborating Centre in Geneva is pushing for global standards—including mandatory reporting of adverse events from traditional remedies.
For patients, the takeaway is clear: context matters. A remedy effective in its cultural setting may not translate safely to another. Dr. Hassan advises, “If you’re using traditional medicine, document your symptoms, dosages, and any conventional treatments. Share this with your doctor—even if they’re skeptical.”
Looking ahead, the EU’s Farm to Pharmacy initiative (2026–2030) aims to bridge this gap by funding 10 pilot programs to test traditional remedies under clinical conditions. If successful, it could redefine how Europe engages with global healthcare traditions.
References
- WHO Global Report on Traditional and Complementary Medicine (2023)
- Lancet Study: “Phytotherapy in Africa: Gaps and Opportunities” (2023)
- JAMA Network Open: “Heavy Metal Contamination in Ayurvedic Medicines” (2022)
- ANSM Herbal Medicinal Products Database (2025)
- Nature Plants: “Safety Profiling of African Herbal Remedies” (2024)
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a healthcare provider before using traditional or herbal remedies.
